Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by PoorOpinion


V.FL

RE:Tip of Iceberg Lithium Resource - Buy-in Group

LOL, "pick up the pace" . Almost exactly two years since they...

February 22, 2018

ATBPF

RE:RE:Introduction and Update

StrikingMoose wrote: Thanks for the post. So they are saying March. Looks...

February 22, 2018

ATBPF

RE:Over thinker

mrdyna wrote: As results are approaching in the next little while, I am sure...

February 22, 2018

ATBPF

RE:RE:Our turn

youngpupper wrote: dwventure wrote: PMN shooted up over 300 % in a week...

February 22, 2018

T.VBNK

RE:30 day & 90 day average trading Volume now 34,224 & 62,032

Interesting to see what versavault is costing, they've announced two...

February 22, 2018

T.TH

Interesting review of approval chances of Ibalizumab

https://www.healthonym.com/ibalizumab-trogarzo-therf-taimed-theratechnologies...

February 21, 2018

V.RHT.H

RE:too much talk

gentle688 wrote: In this bb, too much talk attracted a big shorting trader to...

February 20, 2018

ATBPF

RE:RE:RE:RE:RE:RE:RE:RE:100

The metabolic studies are being done because they need to be done, they need...

February 20, 2018

ATBPF

RE:0.29 is holding so far

What you saying? 1) It's reached its pre-news high at 29? or 2) It looks...

February 20, 2018

ATBPF

RE:RE:RE:RE:RE:RE:100

I agree with you about the dosage issues. The way ATE have come to understand...

February 20, 2018

ATBPF

RE:RE:RE:RE:RE:RE:100

Maybe the refs you're looking for are in the review I linked to earlier...

February 19, 2018

ATBPF

RE:RE:RE:RE:100

The point wasnt about the quality of the drug ( or more accurately what it...

February 19, 2018

ATBPF

RE:RE:RE:RE:100

Newtothegame86 wrote: I could be wrong but from what I have read, FDA didn...

February 18, 2018

ATBPF

RE:RE:100

Another way to look at it. NicOx were developing Naproxcinod an NO releasing...

February 18, 2018

V.RHT.H

RE:RE:Agree, this is just the first reoccurring revenue contract

Well done, you're edging yourself back into the real world but not quite...

February 18, 2018

V.RHT.H

RE:RE:RE:RE:Worth buying at this price?

displayname66 wrote: Hope you took your profit...like i did!! GL My greed...

February 17, 2018

ATBPF

RE:RE:Three weeks away ...maybe less!!

I prefer to think that the NR would be thought out, and passed in front of...

February 16, 2018

ATBPF

RE:RE:RE:Close at 30 cents more ??

Obviously this is a VERY strong day but in some respects it only returning to...

February 16, 2018

T.VBNK

RE:Positive Report

Great article thanks, Varsabank seems to be only at the start of realizing...

February 16, 2018

ATBPF

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:First....

Due dil can identify serious companies, quality science, good business and...

February 15, 2018

Featured Company